Continuous Glucose Monitoring– tag –
-
Goodman Advisory Group Invests $1.29 Million in DexCom Amidst Strong Q1 Performance, Revenue Soars 15% to $1.19 Billion
MarketBeat USA Overview Goodman Advisory Group has made a strategic investment of $1.29 million in DexCom, a leading continuous glucose monitoring (CGM) company, following DexCom's strong first-quarter earnings report. The company achiev... -
Senseonics Presents Eversense 365 Real-World Data at ADA Scientific Sessions, Highlights 180-Day Wear for Unmet CGM Needs
Peninsula Fly Fishers USA Overview Senseonics Holdings presented real-world evidence for its Eversense 365 implantable continuous glucose monitoring (CGM) system during the American Diabetes Association (ADA)'s 86th Scientific Sessions. ... -
i-SENS’s CareSens Air CGM Secures Belgian Reimbursement, Paving the Way for Expanded European Market Penetration
i-SENS (アジア経済新聞経由) South Korea, ベルギー Overview South Korean medical device firm i-SENS has achieved a critical milestone with its "CareSens Air" continuous glucose monitoring (CGM) device, securing public insurance reimbursem... -
FiberSense AG Secures CE Mark for Groundbreaking 28-Day Optical CGM System, Targeting European Market Entry
PR Newswire (The Storm Media経由) Switzerland, EU Overview Swiss medtech firm FiberSense AG has obtained CE Mark approval for its continuous glucose monitoring (CGM) system as a Class IIb medical device under EU Regulation 2017/745. This... -
Ultrahuman Launches M2 Live Metabolic Health Platform in U.S., Integrating Abbott’s OTC Lingo CGM for Prescription-Free Glucose Tracking
PR Newswire USA Overview Ultrahuman, a smart ring manufacturer, has launched 'M2 Live,' a metabolic health platform in the U.S. that integrates data from Abbott's over-the-counter (OTC) continuous glucose monitor (CGM) 'Lingo.' Available... -
Medtronic Enhances MiniMed 780G AID System with New CGM Sensors and Launches Screenless MiniMed Flex Pump
diaTribe.org USA Overview Medtronic has introduced two new continuous glucose monitor (CGM) sensors for its MiniMed 780G automated insulin delivery (AID) system in the U.S.: the 6-day Simplera Sync and the 15-day Instinct (based on Abbot... -
FDA Clears Dexcom’s Stelo, First Over-the-Counter CGM for Non-Insulin-Using Children Aged Two and Older
FDA USA Overview The U.S. FDA has approved Dexcom's Stelo Glucose Biosensor System as the first over-the-counter (OTC) continuous glucose monitor (CGM) for children aged two and older who do not use insulin. This expansion significantly ... -
Implantable and Non-Invasive Continuous Health Sensors Advance Personalized Medicine with AI and Wireless Tech, Enabling Up to 1-Year Subcutaneous Deployment
ELE Times India Overview Continuous health sensors, encompassing both implantable and non-invasive wearables, are fundamentally transforming modern medicine. Continuous glucose monitors (CGMs) for diabetes management stand out as one of ... -
FDA Approves Finger-Prick Free Dexcom Stelo and Abbott Libre CGMs, Revolutionizing Metabolic Management for Non-Insulin Users
Mattioli 1885 / GoodRx USA Overview The FDA has approved continuous glucose monitoring (CGM) systems like Dexcom Stelo and Abbott's Lingo (and FreeStyle Libre series), eliminating the need for traditional finger-prick tests and marking a... -
Google’s Smart Contact Lens for Blood Glucose Monitoring Halted Due to Insufficient Tear-Blood Glucose Correlation
Gizmodo USA Overview Google's (Verily) smart contact lens project for non-invasive blood glucose monitoring, announced in 2014, was discontinued in 2018 due to insufficient correlation between tear glucose and blood glucose levels. Key c...
